Iron Deficiency Anemia Treatment Market: Ferrous Sulfate to Dominate Global Market

Iron-deficiency anemia is a common type of anemia when the body does not have enough iron. Anemia is a medical condition caused due to low healthy red blood cells. RBCs (red blood cells) provide oxygen to body tissues. Iron plays a major role in making hemoglobin which is part of red blood cells. Lack of hemoglobin indicates less oxygen in the body. Hence, it is quite important to maintain iron levels. The human body needs iron for oxygen transport, Cellular respiration. Prevention is better than cure. Iron-deficiency anemia can be prevented through consumption of iron rich foods such as meat, vegetables, fruits, and grains. Vitamin C also helps to prevent iron-deficiency anemia.

Exhaustion and tiredness, dyspnoea, headache, rough and dry skin, tachycardia, neurocognitive dysfunction, restless legs syndrome, hemodynamic instability, brittle nails or hair loss, and yellow sallow skin are the major symptoms of iron-deficiency anemia. There is no sign or symptoms in patients with mild to moderate iron-deficiency anemia.

Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30527

Global Iron-deficiency Anemia Witness Most Promising Rise in Demand:

Iron-deficiency anemia can be diagnosed through medical history and blood tests. Blood tests typically include complete blood count (CBC). Other tests evaluate the level of iron, serum ferritin, and total iron binding capacity or transferrin. Generally, these tests show following results: low ferritin, low serum iron (FE), high transferrin or total iron binding capacity, low mean cellular volume (MCV), low hemoglobin (Hg) and hematocrit (Hct), and low iron saturation. Pregnancy complication, growth issue in children and infants are major complication of iron deficiency anemia. According to National Heart, Lung, and Blood Institute (NHLBI) report, an estimated 20% women of childbearing age have iron-deficiency anemia. Rapid or irregular heartbeat due to low amount oxygen blood leads to major complications such as heart failure or an enlarged heart.

Increasing the risk of haemodilution in pregnancy drive the iron-deficiency anemia market. Changes in lifestyle are playing a major role in propelling the global iron-deficiency anemia market. High cost and lack of awareness are key restraints of the market. The iron-deficiency anemia market can be segmented based on therapy, end-user, and region. In terms of therapy, the market can be categorized into dietary therapy, oral iron therapy, parenteral iron therapy, and red cell transfusion.

In terms of end-user, the iron-deficiency anemia market can be segmented into hospitals, ambulatory surgical centers, and home health care. In terms of revenue, the hospitals segment held a significant share of the iron deficiency anemia market.

Request for Analysis of COVID19 Impact on Iron-deficiency Anemia –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30527

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global Iron-deficiency Anemia.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global Iron-deficiency Anemia.

Key Players of Iron-deficiency Anemia Report:

This report profiles major players in the global Iron-deficiency Anemia based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global Iron-deficiency Anemia is consolidated, with the presence of few global players dominating the market.

Key players in the global iron-deficiency anemia market include Apotex, Luitpold Pharmaceuticals Inc., AMAG Pharmaceuticals, Acceleron Pharma, Inc., Bayer AG, Akebia Therapeutics, Inc., Pharmacosmos A/S.

Buy Iron-deficiency Anemia Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=30527&ltype=S

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Rohit Bhisey

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Back to news